Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Upstream Care Lacking for Many CTO PCI Patients in VA Health System

Yael L. Maxwell

February 08, 2023

News Conference News ACC 2022

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Caitlin E. Cox

April 02, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Conference News EHRA 2019

High-Dose Nifedipine Tied to Higher Cardiac Arrest Risk

Todd Neale

March 18, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Todd Neale

January 19, 2017

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Industry News

Boston Heart Reaches Milestone in Statin Intolerance Testing

September 08, 2015

News Daily News

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

January 29, 2015

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

Jason Kahn

February 12, 2012

Presentation TCT 2012

CYP3A4 Genetic Status May Be Associated with Increased Vulnerability to the Adverse Effect of Calcium Channel Blockers on Clopidogrel Response Variability

Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuk Kang, Hyo Suk Ahn, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

January 03, 2012

Advertisement

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Upstream Care Lacking for Many CTO PCI Patients in VA Health System

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

High-Dose Nifedipine Tied to Higher Cardiac Arrest Risk

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Boston Heart Reaches Milestone in Statin Intolerance Testing

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Better Clopidogrel Response Seen with Increased Smoking Levels

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

CYP3A4 Genetic Status May Be Associated with Increased Vulnerability to the Adverse Effect of Calcium Channel Blockers on Clopidogrel Response Variability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content